Avandia®
Manufacturer:
SmithKline Beecham, and Actos
Uses: Rosiglitazone is an antihyperglycemic agent. It helps the body respond better to insulin and it reduces the amount of sugar produced by the liver. It can help control blood sugar levels.
More Information
 |
| Avandia |
Avandia (rosiglitazone maleate) is an oral antidiabetic agent which acts primarily by increasing insulin sensitivity. Avandia is used in the management of type 2 diabetes mellitus (also known as non-insulin-dependent diabetes mellitus [NIDDM] or adult-onset diabetes). Avandia improves glycemic control while reducing circulating insulin levels.
The labeling has been recently updated to reflect the extensive post marketing experience of the product since its launch in June 1999. The current labeling changes also include safety information regarding the use of Avandia in combination with insulin, an indication for which GlaxoSmithKline (GSK) recently received an approvable letter from the Food and Drug Administration. GSK will work with the FDA to address outstanding points that must be resolved before approval for that use can be obtained. Avandia is not currently indicated for use in combination with insulin.
Side Effects
- The American Heart Association reports that people with moderate or
severe congestive heart failure should not use these glucose lowering drugs.
The study concluded that diabetics who have mild heart disease or any
problems with their kidneys could be at a greater risk of developing
congestive heart failure if they take Avandia.
For more information:
Avandia Consumer Information
Prescription Information
|
